Brain

Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development...

Telerehabilitation Systems Market to Grow by USD 532.9 Million (2024-2028), Rising Chronic Disease Cases Drive Growth, AI-Powered Market Evolution – Technavio

NEW YORK, Jan. 20, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The global telerehabilitation systems...

Medical Gas Blenders Market size to increase by USD 582 Million between 2023 to 2028, Market Segmentation by End-user, Product, Geography, Technavio

NEW YORK, Jan. 17, 2025 /PRNewswire/ -- The global medical gas blenders market size is estimated to grow by USD 582...

GT Medical Technologies Raises $37 Million in Series D to Advance the Expansion of GammaTile® in the U.S. for Patients with Operable Brain Tumors

– Financing Led by Evidity Health Capital –  TEMPE, Ariz., Jan. 16, 2025 /PRNewswire/ -- GT Medical Technologies, Inc. (GT...

error: Content is protected !!